Drug
Talquetamab Tgvs
Talquetamab Tgvs: highest development phase Approved, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| TALVEY | Approved |
Latest
No recent events.
Follow Talquetamab Tgvs on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.